By targeting underlying synovitis, the novel intra-articular liraglutide formulation 4P004 aims to bridge the gap between transient symptom relief and disease modification in knee OA.

Add Yahoo as a preferred source to see more of our stories on Google. The US Food and Drug Administration (FDA) has requested that pharma companies marketing glucagon-like peptide-1 receptor agonists ...

A large real-world study shows lower all-cause mortality and some cardiovascular outcomes with combination therapy; other outcomes lack statistical precision.

Researchers conducted a nationwide, case-control study to explore the relationship between GLP-1 RA use and the risk of developing rheumatoid arthritis.

The incidence of colorectal cancer among users of GLP-1RAs was approximately 36% lower than that observed among aspirin users. The use of GLP-1 receptor antagonist (GLP-1RA) therapy has led to a ...

About The Study: In this large cohort of adults with overweight or obesity without diabetes, fewer than 1 in 4 patients remained on any glucagon-like peptide-1 receptor agonist (GLP-1RA) after 12 ...

SGLT2i initiation was associated with a 19% lower adjusted risk for CKD and a 12% lower rate of AKI events over 5 years compared to GLP-1RA initiation. Initiation of sodium-glucose co-transporter 2 ...

Gan & Lee will receive a $5m upfront payment plus up to $76.1m in milestone payments.

Widely used weight-loss and diabetes drugs show clear benefits, but emerging evidence clarifies their side effects, rare risks, and what clinicians should monitor long term. Review: The science of ...